Metastatic Oropharyngeal Carcinoma

2 clinical trials · Condition

Record	Firm	Date
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population (NCT06997068)	Mayo Clinic	2025-07-09
pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer (NCT05799144)	Michael K. Gibson	2023-07-26

Every clearance here is in the API, with alerts when new ones post.